Data / Form D filings / Annidis Corp
Annidis Corp: Form D filings
Annidis Corp, a biotechnology company in Ottawa, Ontario, Canada, filed 2 Form D notices with the SEC between 2011 and 2012. The latest, on March 29, 2012, reports $50,000 sold of a $50,000 offering to 2 investors.
Find out what Annidis Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 245-2650 QUEENSVIEW DRIVE, Ottawa, Ontario, Canada, K2B 8
- Phone
- (613) 596-1800
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1523828
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 29, 2012 | New notice | $50,000 | $50,000 | $0 | 2 | Mar 16, 2012 | sec.gov |
| Jun 24, 2011 | New notice | $75,000 | $75,000 | $0 | 2 | Jun 9, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Crowley | Director | |
| Brian Baker | Director | |
| Gerald Slemko | Executive Officer, Director | |
| Rony Thomas | Director | |
| Michael Mueller | Director | |
| Timothy McCunn | Director | |
| Zeljko Ribaric | Executive Officer, Director | |
| Robert Devenyi | Director |
Every Form D from the week of Mar 26, 2012 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Annidis Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.